维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="Kyrtsonis"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Serum transforming growth factor-β1 is related to the degree of immunoparesis in patients with multiple myeloma显示文摘	Maria-Christina Kyrtsonis Constantina Repa George (XXXV) Z Dedoussis Athanasia Mouzaki Argyris Simeonidis Marina Stamatelou Alice Maniatis	1998	Medical Oncology1998，，2：	1
2	Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma显示文摘	Kyrtsonis MC Vassilakopoulos TP Kafasi N	2007	Br J Haematol2007，137，：	1
3	Differential diagnosis of Waldenstr? m's macroglobulinemia and other B-cell disorders显示文摘	Pangalis GA Kyrtsonis MC Kontopidou FN	2005	Clin Lymphoma2005，5，4：	1
4	Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma显示文摘	Kyrtsonis M C Vassilakopoulos T P Kafasi N	2007	Br J Haematol2007，137，3：	1
5	Primary treatment of Waldenstr? m macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide 显示文摘	Dimopoulos MA Anagnostopoulos A Kyrtsonis MC	2007	J Clin Oncol2007，25，22：	1
6	Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma显示文摘	Kyrtsonis MC Vassilakopoulos TP Kafasi N	2007	Br J Haematol2007，137，3：	1
7	Treatment of relapsed or refractory Waldenstr m's macroglobulinemia with bortezomib显示文摘	Dimopoulos MA Anagnostopoulos A Kyrtsonis MC	2005	Haematologica2005，90，12：	1
8	Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma 显示文摘	Kyrtsonis MC Maltezas D Tzenou T	2009	Semin Hematol2009，46，：	1
9	Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma 显示文摘	Kyrtsonis MC Vassilakopoulos TP Kafasi N	2007	Br J Haematol2007，137，：	1
10	Prog- nostic value of serum free light chain ratio at diagnosis in multiple myeloma显示文摘	Kyrtsonis M C Vassilakopoulos TP Kafasi N	2007	Br Haematol2007，137，：	1
11	Primary treatment of Waldenstrom macroglobulinemia with dexamethaso ne,rituximab,and cyclophosphamide显示文摘	Dimopoulos MA Amagnostopoulos A Kyrtsonis MC	2007	J Clin Oncol2007，25，22：	1
12	Primary treatment of Waldenstrom macroglobulinemia with dexamethasone,rituximab,and cyclophosphamide显示文摘	Dimopoulos MA Anagnostopoulos A Kyrtsonis MC	2007	J Clin Oncol2007，25，22：	1
13	Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma 显示文摘	Kyrtsonis MC Vassilakopoulos TP Kafasi N	2007	Br J Haematol2007，137，：	1
14	Treatment of relapsed or refractory Waldenstrom's macroglobulinamia with bortezomib显示文摘	Dimopoulos MA Anagnostopoulo A Kyrtsonis MC	2005	Haematologica2005，90，：	1
15	Favorable outcomeof primary cutaneous marginal zone lymphoma treated withintralesional tituximab 显示文摘	Kyrtsonis MC Siakantaris MP Kalpadakis C	2006	Eur J Haematol2006，77，4：	1
16	Expression patterns of TH1 and TH2 cytokine genes in childhood idiopathic thrombocytopenie purpura (ITP)at presentation and their modulation by intravenous immunoglobulin G (IVIG)treatment: their role in prognosis显示文摘	Mouzaki A Theodoropoulou M Gianakopoulos I Vlaha V Kyrtsonis MC	2002	Blood2002，100，5：	1
17	Prima- ry treatment of Waldenstrom's macroglobulinemia with dexamethasone, rituximab and cyclophosphamide 显示文摘	Dimopoulos MA Anagnostopoulos A Kyrtsonis MC	2007	J Clin Oncol2007，25，22：	1
18	Validation of the International Prognostic Scoring System(IPSS)for Waldenstrm's macroglobulinemia(WM)and the importance of serum lactate dehydrogenase(LDH)显示文摘	Kastritis E Kyrtsonis MC Hadjiharissi E	2010	Leuk Res2010，34，10：	1
19	Primary treatment of Wal- denstrom macroglobulinemia with dexamethasone, rit- uximab, and cyclophosphamide 显示文摘	DIMOPOULOS M A ANAGNOSTOPOULOS A KYRTSONIS M C	2007	J Clin Oncol2007，25，：	1
20	Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment 显示文摘	Anagnostopoulos A Zervas K Kyrtsonis M	2006	Clin Lymphoma Myeloma2006，7，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示